Wuhan Keqian Biology Co.,Ltd
SHH: 688526.SS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shanghai Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mulin Chen
- Employees
- 923
- Headquarters
- Wuhan, China
- IPO year
- 2020
- Market cap
- CN¥6.9B
- Website
- https://www.kqbio.com
Loading 688526…
Loading profile data…Frequently asked questions about 688526
What does Wuhan Keqian Biology Co.,Ltd (688526.SS) do?
Wuhan Keqian Biology Co.,Ltd focuses on the research and development, production, sales, and animal epidemic prevention technical services of veterinary biological products in China. It offers vaccines for swine, poultry, and pets, as well as diagnostic reagents. The company was founded in 2001 and is based in Wuhan, China.
Where does 688526.SS trade?
Wuhan Keqian Biology Co.,Ltd (688526.SS) trades on the Shanghai Stock Exchange.
What sector is 688526.SS in?
Wuhan Keqian Biology Co.,Ltd (688526.SS) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Wuhan Keqian Biology Co.,Ltd?
Mulin Chen is the chief executive officer of Wuhan Keqian Biology Co.,Ltd (688526.SS).
Where is Wuhan Keqian Biology Co.,Ltd headquartered?
Wuhan Keqian Biology Co.,Ltd is headquartered in China.
Does 688526.SS pay a dividend?
Yes — Wuhan Keqian Biology Co.,Ltd (688526.SS) paid a trailing twelve-month dividend of CNY 0.43 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 688526.SS go public?
Wuhan Keqian Biology Co.,Ltd (688526.SS) completed its initial public offering in 2020.